Targeting the intestinal microbiota in the pediatric population: A clinical perspective

Nutrition in Clinical Practice

Volumn 27, Issue 2, 2012, Pages 226-234

  Ringel Kulka, Tamar ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

complementary therapies; pediatrics; probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ABDOMINAL PAIN; ACUTE DIARRHEA; ANTIBIOTIC ASSOCIATED DIARRHEA; ATOPIC DERMATITIS; CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; DRUG SAFETY; HUMAN; INFANTILE COLIC; INTESTINE FLORA; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PEDIATRICS; REVIEW; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

CHILD; DISEASE MANAGEMENT; HUMANS; INTESTINES; METAGENOME; PEDIATRICS; PREBIOTICS; PROBIOTICS;

EID: 84859337238     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612439895     Document Type: Review

References (64)

1. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics. 2011 ; 5: 71-86
2. Sekirov I, Russell SL, Antunes L, Finlay B. Gut microbiota in health and disease. Physiol Rev. 2010 ; 90 (3). 859-904
3. Simmon G, Gorbach S. Intestinal flora in health and disease. Gastroenterology. 1984 ; 86 (174). 193
4. Parkes G, Brostoff J, Whelan K, Sanderson J. Gastrointestinal microbiota in irritable bowel syndrome: their role in pathogenesis and treatment. Am J Gastroenterol. 2008 ; 103 (6). 1557-1567
5. Manichanh CC, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006 ; 55 (2). 205-211
6. Ott SSJ, Musfeld M, Wenderoth D, Hampe J, Brant O, Folsch U. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004 ; 53 (5). 685-693
7. Carroll I, Ringel-Kulka T, Keku T, et al. Molecular analysis of the luminal and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2011 ;:
8. Marques T, Wall R, Ross P, Fitzgerald G, Ryan C, Stanton C. Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol. 2010 ; 21 (2). 149-156
9. Adlerberth I, Wold A. Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009 ; 98 (2). 229-238
10. Vael C, Desager K. The importance of the development of the intestinal microbiota in infancy. Curr Opin Pediatr. 2009 ; 21 (6). 794-800
11. Grönlund M, Gueimonde M, Laitinen K, et al. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy. 2007 ; 37 (12). 1764-1772
12. Kozyryskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life. Chest. 2007 ; 131 (6). 1753-1759
13. Risnes K, Belanger K, Murk W, Bracken M. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol. 2011 ; 173 (3). 310-318
14. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011 ; 60 (1). 49-54
15. Report of a Joint FAO/WHO Expert Consultation on Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Geneva, Switzerland: WHO ; 2001 :
16. Gibson GM, Roberfroid M. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995 ; 125 (6). 1401-1412
17. Metchnikoff E The Prolongation of Life: Optimistic Studies. New York & London: Putnam ; 1908 :
18. Tissier H. Traitement des infections intestinales par la méthode de la transformation de la flore bactérienne de l'intestin. C R Soc Biol. 1906 ; 60: 359-361
19. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black R. Efficacy of probiotics in prevention of acute diarrhoea: a meta analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006 ; 6 (6). 374-382
20. Braegger C, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011 ; 52 (2). 238-251
21. Chouraqui JP, Grathwohl D, Labaune J, et al. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr. 2008 ; 87 (5). 1365-1373
22. Thomas D, Greer F. Probiotics and prebiotics in pediatrics. Pediatrics. 2010 ; 126 (6). 1217-1231
23. Huang JS, Bousvaros A, Lee J, Diaz A, Davidson E. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci. 2002 ; 47 (11). 2625-2634
24. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev. 2010 ; (11). CD003048
25. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011 ; 45 (suppl). S149 - S153
26. Szajewska H, Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther. 2009 ; 30 (9). 960-961
27. Johnston B, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2007 ; (2). CD004827
28. Kale-Pradhan PB, Jassal H, Wilhelm S. Role of lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy. 2010 ; 30 (2). 119-126
29. Guandalini SS. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev Clin Immunol. 2010 ; 6 (1). 47-54
30. Rembacken BJ, Snelling A, Hawkey P, Chalmers DM, Axon A. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999 ; 354 (9179). 635-639
31. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004 ; 20 (10). 1133-1141
32. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis. Gut. 2005 ; 54 (2). 242-249
33. Miele E, Pascaraella F, Gianetti E, Quaglietta L, Baldassano R, Staiano A. Effect of a probiotic preparation (vsl#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009 ; 104 (2). 437-443
34. Tursi A, Brandimarte G, Giorgetti G, Forti G, Modeo M, Gigliobianco A. Low-dose balsalazide plus a high potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit. 2004 ; 10 (11). I126 - I131
35. Guslandi M, Mezzi G, Sorghi M, Testoni P. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci. 2000 ; 45 (7). 1462-1464
36. Prantera C, Scribano M, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002 ; 51 (3). 405-409
37. Bousvaros AA, Guandalini S, Baldassano RN, et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005 ; 11 (9). 833-839
38. Marteau PP, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut. 2006 ; 55 (6). 842-847
39. Chermesh II. Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci. 2007 ; 52 (2). 385-389
40. Van Gossum A, Dewit O, Louise R, et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection. Inflamm Bowel Dis. 2007 ; 13 (2). 135-142
41. Szajewska H. Probiotics and prebiotics in preterm infants: where are we? where are we going?. Early Hum Dev. 2010 ; 86: S81 - S86
42. Savino FF. Lactobacillus reuteri (American Type Culture Collection strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007 ; 119 (1). e124 - e130
43. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatric. 2010 ; 126 (3). e526 - e533
44. Dupont CC, Rivero M, Grillon C, Belaroussi N, Kalindjian A., Marin V. α-Lactalbumin-enriched and probiotic-supplemented infant formula in infants with colic: growth and gastrointestinal tolerance. Eur J Clin Nutr. 2010 ; 64 (7). 765-767
45. Chronic abdominal pain in children. Pediatrics. 2005 ; 115 (3). 812-815
46. Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev. 2008 ; (1). CD003019
47. Francavilla RR. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010 ; 126 (6). e1445 - e1452
48. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 2011 ; 33 (12). 1302-1310
49. Guandalini S, Magazzu G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010 ; 51 (1). 24-30
50. Ringel Y, Ringel-Kulka T. The rational and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2011 ; 45: S145 - S148
51. van der Aa LB, Heymans H, van Aalderen W, Sprikkelman A. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol. 2010 ; 21 (2). e355 - e367
52. Kopp MV, Salfeld P. Probiotics and prevention of allergic disease. Curr Opin Clin Nutr Metab Care. 2009 ; 12 (3). 298-303
53. Kalliomäki M, Salminen S, Arvilommi H, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001 ; 357 (9262). 1076-1079
54. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003 ; 361 (9372). 1869-1872
55. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 ; 119 (4). 1019-1021
56. Taylor AL, Dunstan J, Prescott S. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007 ; 119 (1). 184-191
57. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008 ; 121 (4). e850 - e856
58. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007 ; 119 (1). 192-198
59. Abrahamsson T, Jakobsson T, Bottcher M, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 ; 119 (5). 1174-1180
60. Boyle RJ, Bath-Hextall F, Leonardi-Bee J, Murrell D, Tang M. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008 ; (4). CD006135
61. Özdemir Ö. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data various effects of probiotics in allergy. Clin Exp Immunol. 2010 ; 160 (3). 295-304
62. Arslanoglu S, Moro G, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008 ; 138 (6). 1091-1095
63. Rao S, Srinivasjois R, Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med. 2009 ; 163 (8). 755-764
64. Grüber C, Stuijvenberg M, Mosca F, et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol. 2010 ; 126 (4). 791-797